Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Country

Austria (1)
Belgium (2)
Denmark (1)
France (6)
Germany (5)
Italy (3)
Netherlands (3)
Spain (3)
United Kingdom (3)

Advanced search

Search projects and results

Results 1 - 5 of 5
Order by: Results/page:
1
Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome
ID: 755225
Start date: 2018-01-01, End date: 2022-12-31
Crigler-Najjar syndrome (CN) is a rare recessive disorder caused by mutations in the uridine diphosphate glucuronosyltransferase 1A1(UGT1A1) gene. CN is a life-threatening disease with no cure which constitutes a severe burden for the patients, their families, and the society...
Programme: H2020-EU.3.1.3.
Record Number: 212689
Last updated on: 2018-01-23
Clinical Proof of concept for a RNA-targeting Oligonucleotide for a Cystic fibrosis-F508del MEDication
ID: 633545
Start date: 2015-05-01, End date: 2017-12-31
Cystic fibrosis (CF) is a progressive life-shortening disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene leading to a dysfunctional CFTR protein. The disease affects over 70,000 patients worldwide and while many mutations are...
Programme: H2020-EU.3.1.3.
Record Number: 193242
Last updated on: 2017-08-22
ORTHOpedic randomized clinical trial with expanded bone marrow MSC and bioceramics versus autograft in long bone nonUNIONs
ID: 733288
Start date: 2017-01-01, End date: 2021-12-31
Current orthopaedic treatments permit spontaneous bone regeneration to unite and heal 90% bone injuries. Non-union associates pain and disability, often requiring biological enhancement. Regenerative medicine research suggests to the general public that alternative treatments...
Programme: H2020-EU.3.1.3.
Record Number: 207447
Last updated on: 2017-07-24
Chimeric Antigen Receptors (CARs) for Advanced Therapies
ID: 667980
Start date: 2016-01-01, End date: 2019-12-31
Chimeric antigen receptors (CARs) are artificial surface receptors that can be introduced into somatic cells by genetic engineering and that act as recognition molecules like antibodies or T-cell receptors. In this respect, CARs are increasingly used for cellular therapy to...
Programme: H2020-EU.3.1.3.
Record Number: 199744
Last updated on: 2017-06-02
Development of an innovative gene therapy platform to cure rare hereditary muscle disorders
ID: 667751
Start date: 2016-01-01, End date: 2019-12-31
The objective of MYOCURE is to develop an innovative gene therapy platform to cure rare hereditary muscle disorders, specifically focusing on myotubular myopathy (MTM) and glycogen storage disorder (GSD) type II. These are attractive diseases for gene therapy since they...
Programme: H2020-EU.3.1.3.
Record Number: 199738
Last updated on: 2016-11-29
List retrieved on: 2018-08-19
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top